CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tam, S. W.
Right arrow Articles by Schlegel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tam, S. W.
Right arrow Articles by Schlegel, R.

Cell Growth & Differentiation, Vol 3, Issue 11 811-817, Copyright © 1992 by American Association of Cancer Research


ARTICLES

Staurosporine overrides checkpoints for mitotic onset in BHK cells

SW Tam and R Schlegel
Department of Molecular and Cellular Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115.

Under normal conditions, mammalian cells will not initiate mitosis in the presence of either unreplicated or damaged DNA. We report here that staurosporine, a tumor promoter and potent protein kinase inhibitor, can uncouple mitosis from the completion of DNA replication and override DNA damage-induced G2 delay. Syrian hamster (BHK) fibroblasts that were arrested in S phase underwent premature mitosis at concentrations as low as 1 ng/ml, with maximum activity seen at 50 ng/ml. Histone H1 kinase activity was increased to approximately one-half the level found in normal mitotic cells. Inhibition of protein synthesis during staurosporine treatment blocked premature mitosis and suppressed the increase in histone H1 kinase activity. In asynchronously growing cells, staurosporine transiently increased the mitotic index and histone H1 kinase activity but did not induce S phase cells to undergo premature mitosis, indicating a requirement for S phase arrest. Staurosporine also bypassed the cell cycle checkpoint that prevents the onset of mitosis in the presence of damaged DNA. The delay in mitotic onset resulting from gamma radiation was reduced when irradiation was followed immediately by exposure to 50 ng/ml of staurosporine. These findings indicate that inhibition of protein phosphorylation by staurosporine can override two important checkpoints for the initiation of mitosis in BHK cells.


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
T. Kawabe
G2 checkpoint abrogators as anticancer drugs
Mol. Cancer Ther., April 1, 2004; 3(4): 513 - 519.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. T. Rundle, L. Xu, R. J. Andersen, and M. Roberge
G2 DNA Damage Checkpoint Inhibition and Antimitotic Activity of 13-Hydroxy-15-oxozoapatlin
J. Biol. Chem., December 21, 2001; 276(51): 48231 - 48236.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
D. Curman, B. Cinel, D. E. Williams, N. Rundle, W. D. Block, A. A. Goodarzi, J. R. Hutchins, P. R. Clarke, B.-B. Zhou, S. P. Lees-Miller, et al.
Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine
J. Biol. Chem., May 25, 2001; 276(21): 17914 - 17919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. R. Jackson, A. Gilmartin, C. Imburgia, J. D. Winkler, L. A. Marshall, and A. Roshak
An Indolocarbazole Inhibitor of Human Checkpoint Kinase (Chk1) Abrogates Cell Cycle Arrest Caused by DNA Damage
Cancer Res., February 1, 2000; 60(3): 566 - 572.
[Abstract] [Full Text]


Home page
GeneticsHome page
R. Rowley and J. Zhang
Caffeine-Mediated Override of Checkpoint Controls: A Requirement for rhp6 (Schizosaccharomyces pombe)
Genetics, May 1, 1999; 152(1): 61 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. W. Wang, C. Norbury, A. L. Harris, and T. Toda
Caffeine can override the S-M checkpoint in fission yeast
J. Cell Sci., March 15, 1999; 112(6): 927 - 937.
[Abstract] [PDF]


Home page
J Biol ChemHome page
D. Curman, B. Cinel, D. E. Williams, N. Rundle, W. D. Block, A. A. Goodarzi, J. R. Hutchins, P. R. Clarke, B.-B. Zhou, S. P. Lees-Miller, et al.
Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine
J. Biol. Chem., May 25, 2001; 276(21): 17914 - 17919.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1992 by the American Association of Cancer Research.